Gingival crevicular fluid levels of oncostatin M in periodontal conditions

Cytokine

Volumn 50, Issue 3, 2010, Pages 248-252

  Thorat Manojkumar, S ^a   Pradeep, A R ^a   Garg, Garima ^a   Raju, Arjun ^b  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

^b Bengaluru Medical College and Research Institute   (India)

Author keywords

Cytokines; Gingival crevicular fluid; Gingivitis; Oncostatin M; Periodontitis

Indexed keywords

ONCOSTATIN M;

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTITIS; PREVENTIVE DENTISTRY; PRIORITY JOURNAL;

ADULT; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; ONCOSTATIN M; PERIODONTAL DISEASES; PERIODONTAL INDEX;

EID: 77952549233     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.02.002     Document Type: Article

References (23)

1. Kornman K.S., Page R.C., Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997, 14:33-53.
2. Gemmell E., Seymour G.J. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004, 35:21-41.
3. Abbas A.K., Lichtman A.H. Cellular and molecular immunology 2003, Saunders, Philadelphia. 5th ed.
4. Uitto V.J. Gingival crevice fluid - an introduction. Periodontol 2000 2003, 31:9-11.
5. Modur V., Feldhaus M.J., Weyrich A.S., et al. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 1997, 100:158-168.
6. Lu H.-K., Chen Y.-L., Chang H.-C., Li C.-L., Kuo M.Y.-P. Identification of the OPG/RANKL system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontol Res 2006, 41:354-360.
7. Yao L., Pan J., Setiadi H., Patel K.D., McEver R.P. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 1996, 184:81-92.
8. Manicourt D.H., Poilvache P., Van Egeren A., Devogelaer J.P., Lenz M.E., Thonar E.J. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 2000, 43:281-288.
9. Brown T.J., Rowe J.M., Liu J.W., Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol 1991, 147:2175-2180.
10. Lin S.-J., Chen Y.-L., Kuo M.Y.-P., Li C.-L., Lu H.-K. Measurement of gp130 cytokine oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cytokine 2005, 30:160-167.
11. Hui W., Bell M., Carroll G. Diction of oncostatin M in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1997, 56:184-187.
12. Halin U.-R., Agnieszka W., Henryk S., Tadeusz R. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma. Eur Cytokine Netw 2000, 11(3):443-451.
13. Goren I., Kampfer H., Muller E., Schiefelbein D., Pfeilschifter J., Frank S. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J Invest Dermatol 2006, 126:628-637.
14. Song H.Y., Kim M.R., Lee M.J., Jeon E.S., Bae Y.C., Jung J.S., et al. Oncostatin M decreases adiponectin expression and induces dedifferentiation of adipocytes by JAK3 and MEK dependent pathways. Int J Biochem Cell Biol 2007, 39(2):439-449.
15. Cai J., Gill P.S., Masood R., Chandrosoma P., Jung B., Law R.E., et al. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 1994, 145:74-79.
16. Tsai C.-H., Huang F.-M., Chang Y.-C. Immunohistochemical localization of oncostatin M in epithelialized apical periodontitis lesions. Int Endod J 2008, 41:772-776.
17. Sukkar T.Z., Thomason J.M., Cawston T.E., Lakey R., Jones D., Catterall J., et al. Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin downregulates the production of MMP-1 stimulated by pro-inflammatory cytokines. J Periodontol Res 2007, 42:580-588.
18. Loe H., Silness J. Periodontal disease in pregnancy. I: prevalence and severity. Acta Odontol Scand 1963, 21:533.
19. Orozco A., Gemmell E., Bickel M., Seymour G.J. Interleukin 18 and periodontal disease. J Dent Res 2007, 86(7):586-593.
20. Bruce A.G., Hoggatt I.H., Rose T.M. Oncostatin M is a differentiation factor for myeloid leukemia cells. J Immunol 1992, 149:1271-1275.
21. Griffiths G.S. Formation, collection and significance of gingival crevicular fluid. Periodontol 2000 2003, 31:32-42.
22. Tanimura A., McGregor D.H., Anderson H.C. Calcification in atherosclerosis, I: human studies. J Exp Pathol 1986, 2:261-273.
23. Shioi A., Katagi M., Okuno Y., Mori K., Jono S., Koyama H., et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells roles of tumor necrosis factor-α and oncostatin M derived from macrophages. Circ Res 2002, 91:9-16.